In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. uri icon

authors

  • Postmus, Iris
  • Stott, David J
  • Buckley, Brendan M
  • Sattar, Naveed
  • Ford, Ian
  • Westendorp, Rudi G J
  • Jukema, J Wouter
  • Johnson, Paul C D
  • Trompet, Stella
  • de Craen, Anton J M
  • Slagboom, P Eline
  • Devlin, James J
  • Shiffman, Dov
  • Sacks, Frank M
  • Patricia Kearney, MD, PhD

publication date

  • January 1, 2014